A novel mouse model of cutaneous T‐cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy

Mycosis fungoides (MF) is a subtype of cutaneous T‐cell lymphoma (CTCL). Topical or systemic treatment with psoralen, such as 8‐methoxypsoralen (8‐MOP), followed by ultraviolet A (UVA) irradiation (PUVA therapy) is an effective phototherapy for early‐stage MF. However, the efficacy of PUVA therapy f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakahashi, Keiko, Nihira, Kaito, Suzuki, Miyoko, Ishii, Toshihiko, Masuda, Kazuhiro, Mori, Kiyotoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796778/
https://www.ncbi.nlm.nih.gov/pubmed/35801380
http://dx.doi.org/10.1111/exd.14641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796778/
https://www.ncbi.nlm.nih.gov/pubmed/35801380
http://dx.doi.org/10.1111/exd.14641

Ejemplares similares